In this episode of On Record PR, Executive Vice President Sarah Larson goes on record with James Greenwood, senior policy advisor at DLA Piper and retired CEO of the Biotechnology Innovation Organization (BIO), to discuss the rapid response of the biotechnology industry to COVID-19 and process of discovering and creating a lifesaving medication.